世界のバイオインフォマティクス市場(~2027年):製品&サービス別(ナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、データ分析、構造分析、サービス)、用途別(ゲノミクス、プロテオミクス、トランスクリプトミクス)、産業別(医療、動物)

【英語タイトル】Bioinformatics Market by Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis, Structural Analysis, Services), Applications (Genomics, Proteomics, Transcriptomics), & Sectors (Medical, Animal) - Global Forecast to 2027

MarketsandMarketsが出版した調査資料(HIT7543-23)・商品コード:HIT7543-23
・発行会社(調査会社):MarketsandMarkets
・発行日:2022年12月20日
・ページ数:226
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

MarketsandMarkets社は、世界のバイオインフォマティクス市場規模が2022年101億ドルから2027年187億ドルに達し、予測期間中に年平均13.0%で成長すると予測しています。本調査レポートでは、バイオインフォマティクスの世界市場を調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品&サービス別(ナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、データ分析プラットフォーム、構造&機能解析プラットフォーム、バイオインフォマティクスサービス)分析、用途別(ゲノミクス、プロテオミクス、トランスクリプトミクス、メタボロミクス、その他)分析、産業別(医療バイオテクノロジー、動物バイオテクノロジー、植物バイオテクノロジー、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、その他地域)分析、競争状況、企業情報などの項目を掲載しています。なお、当書に掲載されている企業情報には、Thermo Fisher Scientific,Inc. (US)、Eurofins Scientific (Luxembourg)、QIAGEN N.V. (Netherlands)、Agilent Technologies,Inc. (US)、and Illumina,Inc. (US)、Waters Corporation (US)、DNASTAR (US)、NeoGenomics Laboratories (US)、Perkin Elmer,Inc. (US)、GENEWIZ (US) and BGI Group (China) Waters Corporation (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のバイオインフォマティクス市場規模:製品&サービス別
- ナレッジマネジメントツールの市場規模
- バイオインフォマティクスプラットフォームの市場規模
- データ分析プラットフォームの市場規模
- 構造&機能解析プラットフォームの市場規模
- バイオインフォマティクスサービスの市場規模
・世界のバイオインフォマティクス市場規模:用途別
- ゲノミクスにおける市場規模
- プロテオミクスにおける市場規模
- トランスクリプトミクスにおける市場規模
- メタボロミクスにおける市場規模
- その他用途における市場規模
・世界のバイオインフォマティクス市場規模:産業別
- 医療バイオテクノロジーにおける市場規模
- 動物バイオテクノロジーにおける市場規模
- 植物バイオテクノロジーにおける市場規模
- その他産業における市場規模
・世界のバイオインフォマティクス市場規模:地域別
- 北米のバイオインフォマティクス市場規模
- ヨーロッパのバイオインフォマティクス市場規模
- アジア太平洋のバイオインフォマティクス市場規模
- その他地域のバイオインフォマティクス市場規模
・競争状況
・企業情報

“世界のバイオインフォマティクス市場は、2022年の101億米ドルから予測期間中に年平均成長率13.0%で成長し、2027年には187億米ドルに達すると予測”
バイオインフォマティクス市場の成長を牽引しているのは、バイオインフォマティクスに対する公的・民間資金の増加、個別化医療に対する需要の高まり、製薬・バイオテクノロジーの研究開発費の増加、ゲノム配列決定のコスト低下です。しかし、機器のコストが高いことがこの市場の成長を妨げています。

“バイオインフォマティクスサービス分野が予測期間中に最も急成長すると推定”
製品・サービス別に見ると、バイオインフォマティクス市場はナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、バイオインフォマティクスサービスに区分されます。2021年には、ナレッジマネジメントツールセグメントがバイオインフォマティクス市場の最大シェア36.3%を占めました。このセグメントの大きなシェアは、ライフサイエンス研究や創薬で生成される大量のデータを管理するためのナレッジマネジメントツールに対する需要が高まっていることに起因しています。しかし、予測期間中はバイオインフォマティクス・サービス分野が最も急成長すると予測されています。シーケンシングコストの削減と増大するデータ量の管理の必要性、およびゲノム研究に対する政府資金の増加が、この市場セグメントの成長の要因となっています。

“医療バイオテクノロジーが市場の最大セグメントを占める”
分野は、医療バイオ、動物バイオ、植物バイオ、環境バイオ、法医学バイオ、その他に分類されます。2021年のバイオインフォマティクス市場では、医療バイオ分野が50.3%の最大シェアを占めています。創薬のための新しいデータベース、臨床診断のためのバイオインフォマティクスの応用、臨床診断のためのバイオインフォマティクスソリューションを立ち上げるための資金調達機会の増加は、市場における医療バイオテクノロジー分野の成長を促進する主な要因です。

“ゲノム分野がコンポーネント市場で最大シェアを占める”
アプリケーション別に見ると、バイオインフォマティクス市場は、ゲノミクス、ケモインフォマティクス&ドラッグデザイン、プロテオミクス、トランスクリプトミクス、メタボロミクス、その他のアプリケーションに区分されます。2021年の市場シェアはゲノム分野が36.9%で最大。精密医療開発のためのファーマコゲノミクス研究の利用の増加、ゲノム研究に対する有利な資金調達シナリオの拡大、高度なバイオインフォマティクスツールとソフトウェアの開発のための様々なライフサイエンスとインフォマティクス企業間のパートナーシップとコラボレーションの増加が、ゲノミクス向けバイオインフォマティクス市場の成長に寄与する主な要因です。

“北米のバイオインフォマティクス市場を占める米国”
バイオインフォマティクス市場は、2021年には北米が45.1%のシェアを占め、次いで欧州とアジア太平洋地域、その他の地域が続きます。北米は、ヘルスケア産業におけるバイオインフォマティクス・サービス開発のフロントランナーです。米国のバイオインフォマティクス市場は、病院におけるEHRの導入が増加していることから、今後数年間で成長機会がもたらされると期待されています。また、多くの大手グローバル企業が米国に拠点を置いており、米国はバイオインフォマティクス市場における技術革新の中心地となっています。

供給側の一次インタビューの内訳
- 企業タイプ別: Tier1:45%、Tier2:40%、Tier3:15%: 地域別:北米:36%、欧州:29%: 地域別:北米36%、欧州30%、アジア太平洋地域21%、その他地域13%

バイオインフォマティクス市場に参入している有力企業としては、Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China) Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK),Biomax Informatics AG (Germany) などです。

調査範囲
この調査レポートは、バイオインフォマティクス市場を製品・サービス、分野、用途、地域に基づいて調査しています。また、市場成長に影響を与える要因(促進要因、阻害要因、機会、課題など)を調査しています。市場における機会と課題を分析し、市場リーダーのための競争環境の詳細を提供します。さらに、個々の成長動向に関してミクロ市場を分析し、ソースとデスティネーションの2つの主要地域に関して市場セグメントの収益を予測しています。

レポート購入の主な利点
本レポートは、様々なレベルの分析-業界動向、トップ企業の市場シェア、企業プロフィールなど-に焦点を当てており、これらを合わせて基本的な見解を形成し、競争環境、高成長地域とその促進要因、阻害要因、課題、機会を分析しています。本レポートは、既存企業だけでなく、新規参入企業や中小企業にとっても、市場の動向を把握し、より大きな市場シェアを獲得するのに役立ちます。

❖ レポートの目次 ❖

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 MARKET SCOPE 32
1.3.1 INCLUSIONS AND EXCLUSIONS 32
1.3.2 MARKETS COVERED 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY SOURCES 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY SOURCES 37
FIGURE 2 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 4 BIOINFORMATICS MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION (BOTTOM-UP APPROACH) 39
FIGURE 5 BIOINFORMATICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 40
FIGURE 6 CAGR PROJECTIONS: BIOINFORMATICS MARKET 41
FIGURE 7 BIOINFORMATICS MARKET: TOP-DOWN APPROACH 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 8 DATA TRIANGULATION METHODOLOGY 42
2.4 ASSUMPTIONS 43
2.5 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
FIGURE 9 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2027 (USD MILLION) 44
FIGURE 10 BIOINFORMATICS MARKET, BY SECTOR, 2021 VS. 2027 (USD MILLION) 45
FIGURE 11 BIOINFORMATICS MARKET, BY APPLICATION, 2021 VS. 2027 (USD MILLION) 45
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF BIOINFORMATICS MARKET 46
4 PREMIUM INSIGHTS 47
4.1 BIOINFORMATICS MARKET OVERVIEW 47
FIGURE 13 INCREASING PUBLIC AND PRIVATE-SECTOR FUNDING FOR BIOINFORMATICS TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 47
4.2 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE AND REGION 48
FIGURE 14 KNOWLEDGE MANAGEMENT TOOLS SEGMENT TO DOMINATE BIOINFORMATICS MARKET DURING FORECAST PERIOD 48
4.3 BIOINFORMATICS MARKET: GROWTH RATE SNAPSHOT, BY COUNTRY 48
FIGURE 15 INDIA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 48
4.4 BIOINFORMATICS MARKET: REGIONAL MIX 49
FIGURE 16 NORTH AMERICA DOMINATED MARKET IN 2021 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
FIGURE 17 BIOINFORMATICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.1.1 DRIVERS 50
5.1.1.1 Increasing public and private-sector funding for bioinformatics 50
TABLE 1 PUBLIC AND PRIVATE-SECTOR FUNDING FOR BIOINFORMATICS AND RELATED FIELDS 51
5.1.1.2 Growing demand for personalized medicine 52
5.1.1.3 Increasing pharmaceutical and biotechnology R&D expenditure 53
TABLE 2 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN ASIA PACIFIC REGION 53
5.1.1.4 Decreasing cost of genome sequencing 53
5.1.2 RESTRAINTS 54
5.1.2.1 High cost of equipment 54
5.1.3 OPPORTUNITIES 55
5.1.3.1 Lucrative opportunities in emerging markets 55
5.1.3.2 Adoption of blockchain technology and cloud computing 55
5.1.3.3 Integration of machine learning and AI in healthcare 56
5.1.3.4 Investments by leading IT companies in development of bioinformatics solutions 56
5.1.4 CHALLENGES 57
5.1.4.1 Management of large data volumes 57
5.1.4.2 Lack of interoperability and multiplatform capabilities 57
5.1.4.3 Growing competition from in-house development and publicly available tools 58
5.1.4.4 Shortage of skilled bioinformatics professionals 58
5.2 PORTER’S FIVE FORCES ANALYSIS 59
5.2.1 THREAT OF NEW ENTRANTS 59
5.2.2 BARGAINING POWER OF SUPPLIERS 59
5.2.3 BARGAINING POWER OF BUYERS 59
5.2.4 THREAT OF SUBSTITUTES 59
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.3 VALUE CHAIN ANALYSIS 60
FIGURE 18 VALUE CHAIN ANALYSIS: BIOINFORMATICS MARKET 60
5.3.1 RESEARCH AND DEVELOPMENT (R&D) 60
5.3.2 RAW MATERIALS 60
5.3.3 DISTRIBUTION AND AFTER-SALES SERVICES 60
5.4 REGULATORY LANDSCAPE 61
5.4.1 NORTH AMERICA 61
5.4.2 EUROPE 62
5.4.3 ASIA PACIFIC 62
5.4.4 MIDDLE EAST & AFRICA 63
5.4.5 LATIN AMERICA 63
5.5 CASE STUDIES 63
5.6 ECOSYSTEM/MARKET MAP 64
FIGURE 19 BIOINFORMATICS ECOSYSTEM 64
5.7 TECHNOLOGY ANALYSIS 64
TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 64
5.8 INDUSTRY TRENDS 65
5.8.1 DISCOVERY OF BIOMARKERS 65
5.8.2 PROTEIN INTERACTIONS AND PATHWAYS 65
5.8.3 GENETIC INTERACTION DUE TO HUMAN DISEASES 65
5.9 PRICING ANALYSIS 65
TABLE 4 AVERAGE SELLING PRICE OF BIOINFORMATICS SOLUTIONS, BY PRODUCT 66
TABLE 5 AVERAGE SELLING PRICE OF BIOINFORMATICS SOLUTIONS, BY SERVICE 66
5.10 KEY CONFERENCES AND EVENTS 66
TABLE 6 BIOINFORMATICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 66
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 67
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 67
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS 67
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AMONG END USERS 67
5.11.2 BUYING CRITERIA 68
FIGURE 21 KEY BUYING CRITERIA FOR END USERS 68
TABLE 8 KEY BUYING CRITERIA FOR END USERS 68
6 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE 69
6.1 INTRODUCTION 70
TABLE 9 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 70
6.2 KNOWLEDGE MANAGEMENT TOOLS 70
TABLE 10 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 11 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2020–2027 (USD MILLION) 71
TABLE 12 NORTH AMERICA: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 13 EUROPE: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72
TABLE 14 APAC: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72
6.2.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 72
6.2.1.1 Development of novel generalized knowledge management tools to drive growth 72
TABLE 15 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2020–2027 (USD MILLION) 73
6.2.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 73
6.2.2.1 Data security and highly reliable information storage systems to support growth 73
TABLE 16 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2020–2027 (USD MILLION) 74
6.3 BIOINFORMATICS PLATFORMS 74
TABLE 17 BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 18 BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 75
TABLE 19 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 20 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 21 APAC: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
6.3.1 DATA ANALYSIS PLATFORMS 76
6.3.1.1 Increasing need for data analysis during sequencing programs to drive growth 76
TABLE 22 DATA ANALYSIS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 76
6.3.2 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS 77
6.3.2.1 Growing proteomics research worldwide to drive growth 77
TABLE 23 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 77
6.3.3 OTHER BIOINFORMATICS PLATFORMS 77
TABLE 24 OTHER BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION) 78
6.4 BIOINFORMATICS SERVICES 78
TABLE 25 BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 26 BIOINFORMATICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 79
TABLE 27 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
TABLE 28 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 29 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
6.4.1 SEQUENCING SERVICES 80
6.4.1.1 Financial support from government and private bodies to drive growth 80
TABLE 30 SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 81
TABLE 31 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 32 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
TABLE 33 APAC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
6.4.2 DATA ANALYSIS SERVICES 82
6.4.2.1 Growing adoption of big data analytics in life science research to drive growth 82
TABLE 34 DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 83
TABLE 35 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 36 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 37 APAC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4.3 DRUG DISCOVERY SERVICES 84
6.4.3.1 Growing technological advancements in pharmacogenomics to drive growth 84
TABLE 38 DRUG DISCOVERY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 84
TABLE 39 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 40 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 41 APAC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
6.4.4 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES 86
6.4.4.1 Increasing R&D for advancement of solutions and services for differential gene expression studies to drive growth 86
TABLE 42 DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION) 86
TABLE 43 NORTH AMERICA: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
TABLE 44 EUROPE: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
TABLE 45 APAC: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.4.5 DATABASE AND MANAGEMENT SERVICES 87
6.4.5.1 Growing volume of data generated to increase need for database and management services 87
TABLE 46 DATABASE AND MANAGEMENT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 88
TABLE 47 NORTH AMERICA: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 48 EUROPE: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 49 APAC: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
6.4.6 OTHER BIOINFORMATICS SERVICES 89
TABLE 50 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 89
TABLE 51 NORTH AMERICA: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 52 EUROPE: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 53 APAC: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
7 BIOINFORMATICS MARKET, BY APPLICATION 91
7.1 INTRODUCTION 92
TABLE 54 BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 92
7.2 GENOMICS 92
7.2.1 DECREASING COST OF NEXT-GENERATION SEQUENCING TO BOOST GROWTH 92
TABLE 55 GENOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 93
7.3 CHEMOINFORMATICS & DRUG DESIGN 93
7.3.1 GROWING USE IN DRUG DESIGNING PROCESS BY PHARMACEUTICAL COMPANIES TO DRIVE GROWTH 93
TABLE 56 CHEMOINFORMATICS & DRUG DESIGN MARKET, BY REGION, 2020–2027 (USD MILLION) 93
7.4 PROTEOMICS 94
7.4.1 INCREASING APPLICATIONS IN DRUG DISCOVERY TO DRIVE GROWTH 94
TABLE 57 PROTEOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 94
7.5 TRANSCRIPTOMICS 95
7.5.1 TRANSCRIPTOMICS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 95
TABLE 58 TRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 95
7.6 METABOLOMICS 95
7.6.1 INCREASING RESEARCH FUNDING TO DRIVE GROWTH 95
TABLE 59 METABOLOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
7.7 OTHER APPLICATIONS 96
TABLE 60 OTHER APPLICATIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
8 BIOINFORMATICS MARKET, BY SECTOR 97
8.1 INTRODUCTION 98
TABLE 61 BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 98
8.2 MEDICAL BIOTECHNOLOGY 98
TABLE 62 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY SECTOR, 2020–2027 (USD MILLION) 99
TABLE 63 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 99
TABLE 64 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 65 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 66 APAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 100
8.2.1 DRUG DISCOVERY & DEVELOPMENT 100
8.2.1.1 Increasing adoption of bioinformatics services and products for drug designing to drive growth 100
TABLE 67 BIOINFORMATICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION) 101
8.2.2 CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE 101
8.2.2.1 Focus on development of bioinformatics tools for personalized medicine to propel growth 101
TABLE 68 BIOINFORMATICS MARKET FOR CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2020–2027 (USD MILLION) 102
8.2.3 REPRODUCTIVE HEALTH 102
8.2.3.1 Increasing R&D on reproductive health to bolster market growth 102
TABLE 69 BIOINFORMATICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2020–2027 (USD MILLION) 103
8.3 ANIMAL BIOTECHNOLOGY 103
8.3.1 RAPID ADVANCES IN UNDERSTANDING OF FARM ANIMAL GENOMES TO AID MARKET GROWTH 103
TABLE 70 BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 71 NORTH AMERICA: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 72 EUROPE: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 73 APAC: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 105
8.4 PLANT BIOTECHNOLOGY 105
8.4.1 INCREASED USE OF BIOINFORMATICS FOR TIME AND COST-EFFICIENT R&D IN AGRICULTURE TO DRIVE MARKET GROWTH 105
TABLE 74 BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 106
TABLE 75 NORTH AMERICA: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 76 EUROPE: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 77 APAC: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107
8.5 ENVIRONMENTAL BIOTECHNOLOGY 107
8.5.1 INCREASING USE OF NGS FOR ENVIRONMENTAL BIOTECHNOLOGY APPLICATIONS TO DRIVE MARKET GROWTH 107
TABLE 78 BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 79 NORTH AMERICA: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 80 EUROPE: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 81 APAC: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 109
8.6 FORENSIC BIOTECHNOLOGY 109
8.6.1 INCREASING AVAILABILITY OF ADVANCED SOFTWARE FOR INVESTIGATIONAL PURPOSES TO DRIVE GROWTH 109
TABLE 82 BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 109
TABLE 83 NORTH AMERICA: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 84 EUROPE: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 85 APAC: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 110
8.7 OTHER SECTORS 111
TABLE 86 BIOINFORMATICS MARKET FOR OTHER SECTORS, BY REGION, 2020–2027 (USD MILLION) 112
TABLE 87 NORTH AMERICA: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 88 EUROPE: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 89 APAC: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 113
9 BIOINFORMATICS MARKET, BY REGION 114
9.1 INTRODUCTION 115
TABLE 90 BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION) 115
9.2 NORTH AMERICA 115
FIGURE 22 NORTH AMERICA: BIOINFORMATICS MARKET SNAPSHOT (2021) 116
TABLE 91 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 92 NORTH AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 117
TABLE 93 NORTH AMERICA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 94 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 95 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 96 NORTH AMERICA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 119
TABLE 97 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 98 NORTH AMERICA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
9.2.1 US 120
9.2.1.1 US dominated North American market in 2021 120
TABLE 99 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 120
TABLE 100 US: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 101 US: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 102 US: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 103 US: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 122
TABLE 104 US: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 105 US: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122
9.2.2 CANADA 123
9.2.2.1 Growth in genomics field to drive market 123
TABLE 106 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 123
TABLE 107 CANADA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 108 CANADA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 109 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 110 CANADA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 125
TABLE 111 CANADA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 112 CANADA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125
9.3 EUROPE 126
FIGURE 23 EUROPE: BIOINFORMATICS MARKET SNAPSHOT (2021) 127
TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 114 EUROPE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 128
TABLE 115 EUROPE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 116 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 117 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 118 EUROPE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 130
TABLE 119 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 120 EUROPE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
9.3.1 GERMANY 131
9.3.1.1 Germany expected to be largest market for bioinformatics products and services in Europe 131
TABLE 121 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 131
TABLE 122 GERMANY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 123 GERMANY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 124 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 125 GERMANY: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 133
TABLE 126 GERMANY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 127 GERMANY: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133
9.3.2 UK 134
9.3.2.1 Increasing genomics research to drive market growth 134
TABLE 128 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 129 UK: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 130 UK: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 131 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 132 UK: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 136
TABLE 133 UK: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 134 UK: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136
9.3.3 FRANCE 137
9.3.3.1 Government initiatives for genomics research to drive market growth 137
TABLE 135 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137
TABLE 136 FRANCE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 137 FRANCE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 138 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 139 FRANCE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 139
TABLE 140 FRANCE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 141 FRANCE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
9.3.4 ITALY 140
9.3.4.1 Increasing research in genomics to drive market growth 140
TABLE 142 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 140
TABLE 143 ITALY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 144 ITALY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 145 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 146 ITALY: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 142
TABLE 147 ITALY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 148 ITALY: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
9.3.5 SPAIN 143
9.3.5.1 Presence of several local players in Spanish bioinformatics market to drive growth 143
TABLE 149 SPAIN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 143
TABLE 150 SPAIN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 151 SPAIN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 152 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 153 SPAIN: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 145
TABLE 154 SPAIN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 155 SPAIN: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
9.3.6 REST OF EUROPE 146
TABLE 156 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 146
TABLE 157 ROE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 158 ROE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 159 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 160 ROE: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 148
TABLE 161 ROE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 162 ROE: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
9.4 ASIA PACIFIC 149
FIGURE 24 ASIA PACIFIC: BIOINFORMATICS MARKET SNAPSHOT (2021) 149
TABLE 163 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 164 ASIA PACIFIC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 150
TABLE 165 ASIA PACIFIC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 166 ASIA PACIFIC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 167 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 168 ASIA PACIFIC: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 152
TABLE 169 ASIA PACIFIC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 170 ASIA PACIFIC: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
9.4.1 CHINA 153
9.4.1.1 Partnerships and collaborations between various industry stakeholders driving development of bioinformatics 153
TABLE 171 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 153
TABLE 172 CHINA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 173 CHINA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 174 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 175 CHINA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 155
TABLE 176 CHINA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 177 CHINA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
9.4.2 JAPAN 156
9.4.2.1 Growing focus of Japanese bioinformatics firms on product launches and collaborations to drive growth 156
TABLE 178 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 156
TABLE 179 JAPAN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 180 JAPAN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 181 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 182 JAPAN: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 158
TABLE 183 JAPAN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 184 JAPAN: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
9.4.3 INDIA 159
9.4.3.1 Increasing outsourcing of pharmaceutical drug discovery to drive growth 159
TABLE 185 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159
TABLE 186 INDIA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 187 INDIA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 188 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 189 INDIA: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 161
TABLE 190 INDIA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 191 INDIA: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 161
9.4.4 REST OF ASIA PACIFIC 162
TABLE 192 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 162
TABLE 193 ROAPAC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 194 ROAPAC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 195 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 196 ROAPAC: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 164
TABLE 197 ROAPAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 198 ROAPAC: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 164
9.5 REST OF THE WORLD 165
TABLE 199 ROW: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 165
TABLE 200 ROW: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 201 ROW: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 202 ROW: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 203 ROW: BIOINFORMATICS MARKET, BY SECTOR, 2020–2027 (USD MILLION) 167
TABLE 204 ROW: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 205 ROW: BIOINFORMATICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
10 COMPETITIVE LANDSCAPE 168
10.1 INTRODUCTION 168
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 168
TABLE 206 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS 168
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 170
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN BIOINFORMATICS MARKET 170
10.4 MARKET RANKING ANALYSIS, 2021 170
FIGURE 26 RANK OF COMPANIES IN GLOBAL BIOINFORMATICS MARKET, 2021 170
10.5 COMPETITIVE LEADERSHIP MAPPING 171
10.5.1 STARS 171
10.5.2 PERVASIVE PLAYERS 171
10.5.3 EMERGING LEADERS 172
10.5.4 PARTICIPANTS 172
FIGURE 27 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 172
10.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021) 173
10.6.1 PROGRESSIVE COMPANIES 173
10.6.2 STARTING BLOCKS 173
10.6.3 RESPONSIVE COMPANIES 173
10.6.4 DYNAMIC COMPANIES 173
FIGURE 28 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 174
10.7 COMPETITIVE BENCHMARKING 174
TABLE 207 FOOTPRINT OF COMPANIES 175
TABLE 208 PRODUCT & SERVICE FOOTPRINT OF COMPANIES 175
TABLE 209 REGIONAL FOOTPRINT OF COMPANIES 176
10.8 COMPETITIVE SCENARIO 176
10.8.1 PRODUCT & SERVICE LAUNCHES 176
TABLE 210 BIOINFORMATICS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2019–NOVEMBER 2022 176
10.8.2 DEALS 177
TABLE 211 BIOINFORMATICS MARKET: DEALS, JANUARY 2019–NOVEMBER 2022 177
11 COMPANY PROFILES 182
11.1 KEY PLAYERS 182
(Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 182
TABLE 212 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 182
FIGURE 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021) 183
11.1.2 EUROFINS SCIENTIFIC 189
TABLE 213 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 189
FIGURE 30 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021) 189
11.1.3 ILLUMINA, INC. 192
TABLE 214 ILLUMINA, INC.: BUSINESS OVERVIEW 192
FIGURE 31 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 193
11.1.4 PERKINELMER, INC. 198
TABLE 215 PERKINELMER, INC.: BUSINESS OVERVIEW 198
FIGURE 32 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 199
11.1.5 NEOGENOMICS LABORATORIES 202
TABLE 216 NEOGENOMICS LABORATORIES: BUSINESS OVERVIEW 202
FIGURE 33 NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT (2021) 202
11.1.6 QIAGEN N.V. 204
TABLE 217 QIAGEN N.V.: BUSINESS OVERVIEW 204
FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2021) 205
11.1.7 SOURCE BIOSCIENCE 208
TABLE 218 SOURCE BIOSCIENCE: BUSINESS OVERVIEW 208
FIGURE 35 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2021) 209
11.1.8 AGILENT TECHNOLOGIES, INC. 210
TABLE 219 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 210
FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 210
11.1.9 DNASTAR 213
TABLE 220 DNASTAR: BUSINESS OVERVIEW 213
11.1.10 PSOMAGEN, INC. (FORMERLY MACROGEN CORP.) 215
TABLE 221 PSOMAGEN, INC.: BUSINESS OVERVIEW 215
11.2 OTHER PLAYERS 217
11.2.1 WATERS CORPORATION 217
11.2.2 MICROSYNTH 218
11.2.3 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY) 218
11.2.4 MEDGENOME LABS LTD. 219
11.2.5 PARTEK 219
11.2.6 BEIJING GENOMICS INSTITUTE (BGI) 220
11.2.7 BIOMAX INFORMATICS AG 221
11.2.8 SOPHIA GENETICS 222
11.2.9 FIOS GENOMICS 223
11.2.10 GENUITY SCIENCE (FORMERLY WUXI NEXTCODE) 224
11.2.11 PETDX 225
11.2.12 JADBIO 225
11.2.13 BIOSYSTEMS IMMUNOLAB PLC. 226
11.2.14 ASTALAKE BIOSYSTEMS 226
11.2.15 NUCLEOME INFORMATICS PVT. LTD. 227
*Details on Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices made, and weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 228
12.1 DISCUSSION GUIDE 228
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 232
12.3 CUSTOMIZATION OPTIONS 234
12.4 RELATED REPORTS 234
12.5 AUTHOR DETAILS 235



★調査レポート[世界のバイオインフォマティクス市場(~2027年):製品&サービス別(ナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、データ分析、構造分析、サービス)、用途別(ゲノミクス、プロテオミクス、トランスクリプトミクス)、産業別(医療、動物)] (コード:HIT7543-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のバイオインフォマティクス市場(~2027年):製品&サービス別(ナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、データ分析、構造分析、サービス)、用途別(ゲノミクス、プロテオミクス、トランスクリプトミクス)、産業別(医療、動物)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆